
BGLC Technical Analysis Summary (NASDAQ)
Analyze BGLC on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBGLC Technical Analysis Summary (NASDAQ)
BioNexus Gene Lab Corp. (NASDAQ: BGLC) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest BioNexus Gene Lab Corp. on the NASDAQ is awaiting a decisive move. Overall, BioNexus Gene Lab Corp. remains neutral, with indicators showing mixed momentum.
RSI (14): 53.54
Stochastic %K: 62.96
Williams %R: -14.81
Rate of Change (ROC): 1.29
Takeaway:BioNexus Gene Lab Corp. shows strong bullish momentum, with buyers firmly in control.
MACD: -0.02
ADX: 17.89
ATR (14): 0.10
CCI (14): 118.52
Takeaway:BioNexus Gene Lab Corp. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:BioNexus Gene Lab Corp. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:BioNexus Gene Lab Corp. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:BGLC shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:BioNexus Gene Lab Corp. shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.